XML 25 R14.htm IDEA: XBRL DOCUMENT
v3.25.1

Fair Value of Financial Instruments | 3 Months Ended
--- | ---
Mar. 31, 2025
Fair Value Disclosures [Abstract] |
Fair Value of Financial Instruments | Fair Value of Financial Instruments For financial reporting purposes, we follow a fair value hierarchy established under GAAP that is used to determine the fair value of financial instruments. This hierarchy prioritizes relevant market inputs in order to determine an exit price at the measurement date, or the price at which an asset could be sold or a liability could be transferred in an orderly process that is not a forced liquidation or distressed sale. Level 1 inputs are observable inputs that reflect quoted prices for identical assets or liabilities in active markets. Level 2 inputs are observable inputs other than quoted prices for an asset or liability that are obtained through corroboration with observable market data. Level 3 inputs are unobservable inputs that are used when there is little, if any, relevant market activity for the asset or liability required to be measured at fair value. In certain cases, inputs used to measure fair value fall into different levels of the fair value hierarchy. In such cases, the level at which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. Our assessment of the significance of a particular input requires judgment and considers factors specific to the asset or liability being measured. Determination of Fair Value Included in Note 6 to the Consolidated Financial Statements of our Annual Report on Form 10-K for the year ended December 31, 2024 is a more detailed description of our financial instruments measured at fair value and their significant inputs, as well as the general classification of such instruments pursuant to the Level 1, Level 2, and Level 3 valuation hierarc hy. At March 31, 2025, our valuation policy and processes had not changed from those described in our Annual Report on Form 10-K for the year ended December 31, 2024. The following table presents the assets and liabilities that are reported at fair value on our consolidated balance sheets on a recurring basis at March 31, 2025 and December 31, 2024, as well as the fair value hierarchy of the valuation inputs used to measure fair value. Table 6.1 – Assets and Liabilities Measured at Fair Value on a Recurring Basis
March 31, 2025 |  | Fair Value |  | Fair Value Measurements Using
(In Thousands) |  |  | Level 1 |  | Level 2 |  | Level 3
Assets |  |  |  |  |  |  |  |
Residential consumer loans |  | $ | 12,752,258 |  |  | $ | — |  |  | $ | — |  |  | $ | 12,752,258 |
Residential investor loans |  | 4,439,834 |  |  | — |  |  | — |  |  | 4,439,834 |
Consolidated Agency multifamily loans |  | 423,673 |  |  | — |  |  | — |  |  | 423,673 |
HEI |  | 600,386 |  |  | — |  |  | — |  |  | 600,386 |
Real estate securities: |  |  |  |  |  |  |  |
Trading |  | 171,363 |  |  | — |  |  | — |  |  | 171,363 |
AFS |  | 204,602 |  |  | — |  |  | — |  |  | 204,602 |
Servicing investments |  | 298,290 |  |  | — |  |  | — |  |  | 298,290 |
Strategic investments |  | 3,460 |  |  | — |  |  | — |  |  | 3,460 |
Derivative assets |  | 158,909 |  |  | 11,154 |  |  | 126,250 |  |  | 21,505 |
Total Assets |  | $ | 19,052,775 |  |  | $ | 11,154 |  |  | $ | 126,250 |  |  | $ | 18,915,371 |
Liabilities |  |  |  |  |  |  |  |
ABS issued |  | $ | 14,127,674 |  |  | $ | — |  |  | $ | — |  |  | $ | 14,127,674 |
Derivative liabilities |  | 12,835 |  |  | 8,137 |  |  | — |  |  | 4,698 |
Non-controlling interest |  | 106,160 |  |  | — |  |  | — |  |  | 106,160 |
Total Liabilities |  | $ | 14,246,669 |  |  | $ | 8,137 |  |  | $ | — |  |  | $ | 14,238,532 |
December 31, 2024 |  | Fair Value |  | Fair Value Measurements Using
(In Thousands) |  |  | Level 1 |  | Level 2 |  | Level 3
Assets |  |  |  |  |  |  |  |
Residential consumer loans |  | $ | 11,077,823 |  |  | $ | — |  |  | $ | — |  |  | $ | 11,077,823 |
Residential investor loans |  | 4,587,090 |  |  | — |  |  | — |  |  | 4,587,090 |
Consolidated agency multifamily loans |  | 424,597 |  |  | — |  |  | — |  |  | 424,597 |
HEI |  | 589,785 |  |  | — |  |  | — |  |  | 589,785 |
Real estate securities: |  |  |  |  |  |  |  |
Trading |  | 193,749 |  |  | — |  |  | — |  |  | 193,749 |
AFS |  | 211,474 |  |  | — |  |  | — |  |  | 211,474 |
Servicing investments |  | 297,683 |  |  | — |  |  | — |  |  | 297,683 |
Strategic investments |  | 3,460 |  |  | — |  |  | — |  |  | 3,460 |
Derivative assets |  | 46,003 |  |  | 16,446 |  |  | 23,738 |  |  | 5,819 |
Total Assets |  | $ | 17,431,664 |  |  | $ | 16,446 |  |  | $ | 23,738 |  |  | $ | 17,391,480 |
Liabilities |  |  |  |  |  |  |  |
ABS issued |  | $ | 12,879,530 |  |  | $ | — |  |  | $ | — |  |  | $ | 12,879,530 |
Derivative liabilities |  | 23,660 |  |  | 23,164 |  |  | — |  |  | 496 |
Non-controlling interest |  | 99,510 |  |  | — |  |  | — |  |  | 99,510 |
Total Liabilities |  | $ | 13,002,700 |  |  | $ | 23,164 |  |  | $ | — |  |  | $ | 12,979,536 |
The following table presents additional information about Level 3 assets and liabilities measured at fair value on a recurring basis for the three months ended March 31, 2025. Table 6.2 – Changes in Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis
|  | Assets
|  | Residential Consumer Loans |  | Residential Investor Loans |  | Consolidated Agency Multifamily Loans |  | HEI |  | Real Estate Trading Securities |  | Real Estate AFS Securities |  | Servicing Investments |  | Strategic Investments |  | Derivatives, net (1)
(In Thousands) |  |  |  |  |  |  |  |  |
Beginning balance - December 31, 2024 |  | $ | 11,077,823 |  |  | $ | 4,587,090 |  |  | $ | 424,597 |  |  | $ | 589,785 |  |  | $ | 193,749 |  |  | $ | 211,474 |  |  | $ | 297,683 |  |  | $ | 3,460 |  |  | $ | 5,323 |
Acquisitions |  | 2,383,197 |  |  | 6,800 |  |  | — |  |  | — |  |  | 8,359 |  |  | 844 |  |  | — |  |  | — |  |  | — |
Originations |  | — |  |  | 454,362 |  |  | — |  |  | 1,834 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Sales |  | (423,972) |  |  | (346,455) |  |  | — |  |  | — |  |  | (2,714) |  |  | (11,673) |  |  | — |  |  | — |  |  | — |
Principal paydowns |  | (423,920) |  |  | (287,639) |  |  | (2,294) |  |  | (10,348) |  |  | (162) |  |  | (96) |  |  | 1,956 |  |  | — |  |  | — |
Consolidation of securitized bridge loans (2) |  | — |  |  | 43,383 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Gains (losses) in net income, net |  | 139,976 |  |  | (15,221) |  |  | 1,370 |  |  | 19,048 |  |  | (27,869) |  |  | 681 |  |  | (1,349) |  |  | — |  |  | 31,254 |
Unrealized gains in OCI, net |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 3,372 |  |  | — |  |  | — |  |  | — |
Other settlements, net (3) |  | (846) |  |  | (2,486) |  |  | — |  |  | 67 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (19,770) |
Ending balance - March 31, 2025 |  | $ | 12,752,258 |  |  | $ | 4,439,834 |  |  | $ | 423,673 |  |  | $ | 600,386 |  |  | $ | 171,363 |  |  | $ | 204,602 |  |  | $ | 298,290 |  |  | $ | 3,460 |  |  | $ | 16,807 |
Change in unrealized gains or (losses) for the period included in earnings for assets held at the end of the reporting period (4) |  | $ | 132,299 |  |  | $ | (16,696) |  |  | $ | 1,340 |  |  | $ | 18,495 |  |  | $ | (27,693) |  |  | $ | 3,422 |  |  | $ | (1,053) |  |  | $ | — |  |  | $ | 16,807 |
|  | Liabilities
|  | ABS Issued |  | Non-controlling interest
(In Thousands) |  |
Beginning balance - December 31, 2024 |  | $ | 12,879,530 |  |  | $ | 99,510 |
Acquisitions |  | 1,625,956 |  |  | — |
Sales |  | — |  |  | — |
Principal paydowns |  | (503,956) |  |  | (1,187) |
Gains (losses) in net income (loss), net |  | 126,144 |  |  | 5,997 |
Other settlements, net |  | — |  |  | 1,840 |
Ending balance - March 31, 2025 |  | $ | 14,127,674 |  |  | $ | 106,160 |
Change in unrealized gains or (losses) for the period included in earnings for liabilities held at the end of the reporting period (4) |  | $ | 97,883 |  |  | $ | (4,640) |
(1)For the purpose of this presentation, derivative assets and liabilities, which consist of loan purchase commitments, are presented on a net basis. (2)In the fourth quarter of 2024, we completed our first CAFL securitization sponsored by our joint venture that we consolidate under GAAP as we are the primary beneficiary. During the three months ended March 31, 2025, we transferred $43 million of residential investor bridge loans to the joint venture under the replenishment feature of this securitization. For additional information on our principles of consolidation, see Note 16 of the Notes to Consolidated Financial Statements, included in Part I, Item 1 of the 2025 Quarterly Report on Form 10-Q. (3)Other settlements, net: for residential consumer and residential investor loans, primarily represents the transfer of loans to REO; for HEI, represents the share of HEI disposition fees paid to our third party originators for our purchased HEI portfolio; for derivatives, represents the transfer of the fair value of loan purchase and interest rate lock commitments at the time loans are acquired to the basis of residential consumer and investor loans; and for mortgage servicing rights ("MSRs) and other investments, primarily represents an investment that was exchanged into a new instrument that is no longer measured at fair value on a recurring basis. Footnotes to table 6.2 continued (4)All changes in unrealized gains or (losses) are included in net income, with the exception of Real Estate AFS Securities, which are included in comprehensive income. The following table provides quantitative information about the significant unobservable inputs used in the valuation of our Level 3 assets and liabilities measured at fair value. Table 6.3 – Fair Value Methodology for Level 3 Financial Instruments
March 31, 2025 |  | Fair Value (1) |  |  |  | Input Values
(Dollars in Thousands, except Input Values) |  |  | Unobservable Input |  | Range |  |  | Weighted Average (2)
Assets |  |  |  |  |  |  |  |  |  |  |  |
Residential consumer loans (4) |  | $ | 12,752,258 |  | Senior credit spread to TBA price (3) |  | $ | 0.94 |  | - | $ | 1.81 |  |  |  | $ | 1.06 |  |
|  |  |  | Senior credit spread to Swap rate (3) |  | 130 |  | - | 300 |  | bps |  | 186 |  | bps
|  |  |  | Subordinate credit spread to Swap rate |  | 170 |  | - | 625 |  | bps |  | 268 |  | bps
|  |  |  | Senior credit support (3) |  | 7 |  | - | 7 |  | % |  | 7 |  | %
|  |  |  | IO discount rate (3) |  | 7 |  | - | 22 |  | % |  | 19 |  | %
|  |  |  | Liability price |  | $ | 27 |  | - | $ | 103 |  |  |  | $ | 96 |  |
Residential investor loans: |  |  |  |  |  |  |  |  |  |  |  |
Residential investor term loans (4) |  | 2,559,176 |  |  | Whole loan spread (3) |  | 245 |  | - | 245 |  | bps |  | 245 |  | bps
|  |  |  | Liability price |  | $ | 90 |  | - | $ | 100 |  |  |  | $ | 94 |  |
Residential investor bridge loans (4) |  | 1,880,658 |  |  | Whole loan discount rate |  | 7 |  | - | 13 |  | % |  | 8 |  | %
|  |  |  | Whole loan spread |  | 445 |  | - | 445 |  | bps |  | 445 |  | bps
|  |  |  | Liability Price |  | $ | 101 |  | - | $ | 134 |  |  |  | $ | 102 |  |
|  |  |  | Dollar price of non-performing loans |  | $ | 38 |  | - | $ | 100 |  |  |  | $ | 80 |  |
Consolidated agency multifamily loans(6) |  | 423,673 |  | Liability price |  | $ | 99 |  | - | $ | 99 |  |  |  | $ | 99 |  |
HEI |  | 600,386 |  | Discount rate |  | 10 |  | - | 10 |  | % |  | 10 |  | %
|  |  |  | Prepayment rate (Annual CPR) |  | 1 |  | - | 20 |  | % |  | 14 |  | %
|  |  |  | Home price appreciation (depreciation) |  | 4 |  | - | 4 |  | % |  | 4 |  | %
|  |  |  | Liability price (4) |  | $ | 142 |  | - | $ | 199 |  |  |  | $ | 160 |  |
Real estate securities - trading and AFS securities |  | 375,965 |  | Discount rate |  | 5 |  | - | 40 |  | % |  | 13 |  | %
|  |  |  | Prepayment rate (Annual CPR) |  | — |  | - | 50 |  | % |  | 10 |  | %
|  |  |  | Default rate |  | — |  | - | 8 |  | % |  | — |  | %
|  |  |  | Loss severity |  | 25 |  | - | 50 |  | % |  | 24 |  | %
Servicing investments |  | 298,290 |  | Prepayment rate (Annual CPR) |  | 2 |  | - | 50 |  | % |  | 13 |  | %
|  |  |  | Discount rate |  | 8 |  | - | 19 |  | % |  | 13 |  | %
Derivative assets, net (7) |  | 16,807 |  | Senior credit spread to TBA price (3) |  | $ | 0.94 |  | - | $ | 1.81 |  |  |  | $ | 1.06 |  |
|  |  |  | Senior credit spread to Swap rate (3) |  | 130 |  | - | 300 |  | bps |  | 186 |  | bps
|  |  |  | Subordinate credit spread to Swap rate |  | 170 |  | - | 625 |  | bps |  | 268 |  | bps
|  |  |  | Senior credit support (3) |  | 7 |  | - | 7 |  | % |  | 7 |  | %
|  |  |  | IO discount rate (3) |  | 7 |  | - | 22 |  | % |  | 19 |  | %
|  |  |  | Pull-through rate |  | 1 |  | - | 100 |  | % |  | 58 |  | %
Strategic investments |  | 3,460 |  | Transaction Price |  | $ | 200 |  | - | $ | 1,000 |  |  |  | $ | 494 |  |
Total Assets |  | $ | 18,910,673 |  |  |  |  |  |  |  |  |  |  |
March 31, 2025 |  | Fair Value (1) |  |  |  | Input Values
(Dollars in Thousands, except Input Values) |  |  | Unobservable Input |  | Range |  |  | Weighted Average (2)
Liabilities |  |  |  |  |  |  |  |  |  |  |  |
ABS issued (4) |  | $ | 14,127,674 |  | Discount rate |  | 4 |  | - | 18 |  | % |  | 6 |  | %
|  |  |  | Prepayment rate (annual CPR) |  | — |  | - | 57 |  | % |  | 5 |  | %
|  |  |  | Default rate |  | — |  | - | 13 |  | % |  | — |  | %
|  |  |  | Loss severity |  | — |  | - | 50 |  | % |  | 3 |  | %
Non-controlling interests (8) |  | 106,160 |  | Discount rate |  | 13 |  | - | 20 |  | % |  | 16 |  | %
Total Liabilities |  | $ | 14,233,834 |  |  |  |  |  |  |  |  |  |  |
(1)The predominant valuation technique used to determine our Level 3 fair value assets and liabilities is based on the discounted cash flow model. (2)The weighted average input values for all loan types are based on unpaid principal balance. The weighted average input values for all other assets and liabilities are based on relative fair value. (3)Values represent pricing inputs used in a securitization pricing model. Credit spreads represent spreads to applicable swap rates unless specified otherwise. (4)The fair value of the loans and HEI held by consolidated entities is based on the fair value of the ABS issued by these entities and the securities and other investments we own in those entities, which we determined were more readily observable in accordance with accounting guidance for Collateralized Financing Entities ("CFE"). At March 31, 2025, the fair value of securities we owned at the consolidated Sequoia, CAFL Term, Freddie Mac SLST, and Freddie Mac K-Series was $533 million, $327 million, $264 million and $36 million, respectively. At March 31, 2025, the fair value of our securities in the two CAFL Bridge loan securitizations accounted for under the CFE election and our HEI securitization entities was $29 million and $50 million, respectively. (5)Represents the estimated average duration of outstanding servicer advances at a given point in time (not taking into account new advances made with respect to the pool). (6)Consolidated agency multifamily loans represent securitized financial assets and liabilities of the Company's CFEs. (7)For the purpose of this presentation, derivative assets and liabilities, which consist of loan purchase commitments, are presented on a net basis. (8)Of the total $130 million payable to non-controlling interests, $106 million is measured at fair value on a recurring basis. The following table summarizes the estimated fair values of assets and liabilities that are not measured at fair value at March 31, 2025 and December 31, 2024. Table 6.4 – Carrying Values and Estimated Fair Values of Assets and Liabilities
|  |  |  | March 31, 2025 |  | December 31, 2024
|  | Level in Fair Value Hierarchy |  | Carrying Value |  | Estimated Fair Value |  | Carrying Value |  | Estimated Fair Value
(In Thousands) |  |  |  |  |
Assets |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | 1 |  | $ | 259,918 |  |  | $ | 259,918 |  |  | $ | 245,165 |  |  | $ | 245,165 |
Restricted cash |  | 1 |  | 86,557 |  |  | 86,557 |  |  | 67,762 |  |  | 67,762 |
Liabilities |  |  |  |  |  |  |  |  |  |
Debt obligation facilities and other financing |  | 2 |  | $ | 3,028,525 |  |  | $ | 3,029,522 |  |  | $ | 2,818,292 |  |  | $ | 2,819,393 |
ABS issued, net |  | 3 |  | 330,569 |  |  | 332,661 |  |  | 390,674 |  |  | 392,344 |
Convertible notes, net |  | 1 |  | 366,374 |  |  | 368,369 |  |  | 365,739 |  |  | 365,455 |
Trust preferred securities and subordinated notes, net |  | 3 |  | 138,871 |  |  | 89,280 |  |  | 138,860 |  |  | 93,465 |
Senior Notes |  | 1 |  | 226,915 |  |  | 233,134 |  |  | 139,989 |  |  | 146,716 |
Guarantee obligations (1) |  | 3 |  | 2,447 |  |  | 2,836 |  |  | 2,806 |  |  | 3,204 |
(1)These liabilities are included in Accrued expenses and other liabilities on our consolidated balance During the three months ended March 31, 2025, we elected the fair value option for $8 million of securities, $2.34 billion (principal balance) of residential consumer loans, and $461 million (principal balance) of residential investor loans. Additionally, during the three months ended March 31, 2025, we elected the fair value option for $2 million of newly originated HEI. Nonrecurring Fair Values We measure the fair value of certain assets and liabilities on a nonrecurring basis when events or changes in circumstances indicate that the carrying value may be impaired. Adjustments to fair value generally result from the write-down of asset values due to impairment. REO in Other Assets and Liabilities are classified as Level 3 in the fair value hierarchy based upon fair value determinations using appraisals, broker price opinions, comparable properties or other indications of value. Refer to Note 15 for further information on our REO.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 107 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 100 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2E -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 940 -SubTopic 820 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration